Palisade Bio Reports P-II Study (PROFILE) Results of LB1148 for Post-Surgical Abdominal Adhesions
Shots:
- The P-II study (PROFILE) evaluating LB1148 in patients undergoing elective bowel resection surgery
- The study failed to meet its primary efficacy EPs of reducing adhesions in LB1148 treated patient’s vs PBO treated patients post bowel resection surgery, 16 SAEs were reported in the LB1148 group (3 related to LB1148) vs 14 in PBO
- Additionally, the company focuses on the development of novel therapeutics that target and improve the integrity of the gastrointestinal barrier & identify the opportunities to acquire and or in-license development programs within the GI space
Ref: Palisade | Image: Palisade
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Neha is a Senior Editor at PharmaShots. She is passionate and very enthusiastic about recent updates and developments in the life sciences and pharma industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots. She can be contacted at connect@pharmashots.com.
